Clinical Trials in North Carolina

Showing 12321-12340 of 17,526 trials

DMT210 Topical Gel in the Treatment of Acne Rosacea

NCT03003104

The study evaluates the safety, tolerability, and efficacy of DMT210 Gel, 5% when applied twice daily for 12 weeks in adult patients with moderate to severe acne rosacea. Half of participants will receive DMT210 Gel while the other half will receive vehicle control.

Acne Rosacea

Dermata Therapeutics107 participantsStarted Jan 2017

San Diego, California, United States • Miami, Florida, United States • Fridley, Minnesota, United States +6 more locations

COMPLETEDNA25 miles

A Multicenter Study of 074-6751 Lotion in Subjects With Moderate Plaque Psoriasis

NCT03167515

The primary objective of this study is to determine the efficacy and safety of 074-6751 Lotion applied twice daily for four weeks (28 days) in clinical subjects with moderate plaque psoriasis.

Plaque Psoriasis

Ferndale Laboratories, Inc.95 participantsStarted May 2017

Tampa, Florida, United States • Carmel, Indiana, United States • Plainfield, Indiana, United States +2 more locations

COMPLETED41 miles

Patient, Physician, and Nurse Factors Associated With Entry Onto Clinical Trials and Finishing Treatment in Patients With Primary or Recurrent Uterine, Endometrial, or Cervical Cancer

NCT01098630

This clinical trial is studying patient, physician, and nurse factors associated with entry onto clinical trials and finishing treatment in patients with primary or recurrent uterine, endometrial, or cervical cancer. Determining how patients make decisions about participating in a clinical trial may help doctors plan clinical trials in which more patients are willing to participate and are satisfied with their decision to participate.

Recurrent Cervical CarcinomaRecurrent Uterine Corpus CarcinomaRecurrent Uterine Corpus Sarcoma+15 more

Gynecologic Oncology Group778 participantsStarted Jul 2010

Phoenix, Arizona, United States • Tucson, Arizona, United States • Burbank, California, United States +164 more locations

DMT210 Topical Gel in the Treatment of Acne Rosacea

A Multicenter Study of 074-6751 Lotion in Subjects With Moderate Plaque Psoriasis

Patient, Physician, and Nurse Factors Associated With Entry Onto Clinical Trials and Finishing Treatment in Patients With Primary or Recurrent Uterine, Endometrial, or Cervical Cancer

Find Trials by Condition in North Carolina

Long-Term Extension Study of Intepirdine (RVT-101) in Subjects With Dementia With Lewy Bodies: HEADWAY-DLB Extension

Open-Label, Chronic Exposure, Safety Study of CLONICEL (Clonidine HCl Sustained Release) in Children and Adolescents With Attention Deficit Hyperactivity Disorder (ADHD)

Methotrexate in Induction and Maintenance of Steroid Free Remission in Ulcerative Colitis

Improvement in Wound Healing With Negative Pressure Wound Therapy for Postoperative Total Hip Arthroplasty

Study of VX-661 Alone and in Combination With Ivacaftor in Subjects Homozygous or Heterozygous to the F508del-Cystic Fibrosis Transmembrane Conductance Regulator(CFTR) Mutation

A Phase 2B Open-Label, Single-Arm, Repeat-Dose Study to Evaluate the Reliability of an Autoinjector

Fosamprenavir Versus Other Protease Inhibitors

A Study in Participants With Type 2 Diabetes Mellitus

Registry of Non-primary Angioplasty at Hospitals Without Surgery On-site

R115777 to Treat Children With Neurofibromatosis Type 1 and Progressive Plexiform Neurofibromas

Once-Daily Investigational Nasal Spray In Adults And Adolescents With Perennial Allergic Rhinitis (PAR)

A Study Assessing the Safety and Efficacy of DE-117 Ophthalmic Solution in Patients With POAG or OHT

A Study for Patients With Type 1 Diabetes

Multi-center Study Assessing the Safety and Efficacy of DE-117 Ophthalmic Solution in Subjects With Primary Open-angle Glaucoma or Ocular Hypertension

Study to Assess the Safety, Tolerability, PK and PD Response of PE0139 Injection in Adult Subjects With T2DM

Dose Escalation Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of REMD-477 in Subjects With Type 2 Diabetes Mellitus

Validation of Macimorelin as a Test for Adult Growth Hormone Deficiency